Picture
SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare

PUBLISHER: The Business Research Company | PRODUCT CODE: 1855950

Cover Image

PUBLISHER: The Business Research Company | PRODUCT CODE: 1855950

Pharmaceutical Digital Platform Global Market Report 2025

PUBLISHED:
PAGES: 250 Pages
DELIVERY TIME: 2-10 business days
SELECT AN OPTION
PDF (Single User License)
USD 4490
PDF (Site License)
USD 6490
PDF (Enterprise License)
USD 8490

Add to Cart

A pharmaceutical digital platform is a technology-driven framework designed to integrate digital tools, data systems, and communication channels within the pharmaceutical ecosystem. It provides a centralized environment that enhances information management, facilitates coordination among stakeholders, and strengthens decision-making processes.

The primary types of pharmaceutical digital platforms include teleconsultation, in-person care, vaccine scheduling, and medicine delivery. Teleconsultation involves remote medical consultations between a patient and a healthcare provider using digital communication technologies such as video calls, phone, or messaging. These platforms are used for multiple diseases, including migraine, diabetes, obesity, pneumococcal pneumonia, flu, and others, with applications in both disease treatment and prevention.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The sudden escalation of U.S. tariffs and the consequent trade frictions in spring 2025 are severely impacting the pharmaceutical companies contend with tariffs on APIs, glass vials, and lab equipment inputs with few alternative sources. Generic drug makers, operating on razor-thin margins, are especially vulnerable, with some reducing production of low-profit medicines. Biotech firms face delays in clinical trials due to tariff-related shortages of specialized reagents. In response, the industry is expanding API production in India and Europe, increasing inventory stockpiles, and pushing for trade exemptions for essential medicines.

The pharmaceutical digital platform market research report is one of a series of new reports from The Business Research Company that provides pharmaceutical digital platform market statistics, including the pharmaceutical digital platform industry global market size, regional shares, competitors with the pharmaceutical digital platform market share, detailed pharmaceutical digital platform market segments, market trends, and opportunities, and any further data you may need to thrive in the pharmaceutical digital platform industry. This pharmaceutical digital platform market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The pharmaceutical digital platform market size has grown exponentially in recent years. It will grow from $6.27 billion in 2024 to $8.02 billion in 2025 at a compound annual growth rate (CAGR) of 27.9%. Growth in the historic period was driven by increasing adoption of telemedicine solutions, rising prevalence of chronic diseases, higher demand for patient engagement tools, growing digital transformation in healthcare, and expanded use of electronic health records.

The pharmaceutical digital platform market size is expected to see exponential growth in the next few years. It will grow to $21.24 billion in 2029 at a compound annual growth rate (CAGR) of 27.5%. Growth in the forecast period is expected to result from a stronger focus on personalized medicine, rising demand for remote healthcare services, increased government support for digital health, growing patient preference for convenience, and greater integration of artificial intelligence in healthcare platforms. Primary trends anticipated for the forecast period include advancements in remote patient monitoring technologies, enhanced use of predictive analytics for treatment, development of mobile health applications, innovation in digital therapeutics solutions, and advanced integration of blockchain for data security.

The growing internet penetration is expected to drive the expansion of the pharmaceutical digital platform market in the coming years. The internet serves as a global network connecting computers and devices that communicate and exchange data using standardized protocols. The widespread availability of affordable smartphones has made online access more accessible, improving internet penetration across various regions and income levels. As internet access becomes more widespread, the demand for pharmaceutical digital platforms increases, offering patients easier ways to access healthcare services online, manage medications, and retrieve medical information from any location. For example, a report from the International Telecommunication Union, published in November 2022, indicated that approximately 5.3 billion people-about 66% of the world's population-used the internet in 2022, marking a 6.1% growth from the previous year. This growth in internet penetration is a key driver of the pharmaceutical digital platform market's growth.

Companies in the pharmaceutical digital platform market are increasingly adopting advanced technologies such as automated ingestion engines to improve clinical data aggregation. These systems automatically collect, standardize, and integrate data from various sources into a unified platform, eliminating the need for manual input. For instance, in October 2022, Veeva Systems Inc., a cloud-based software company from the United States, introduced Veeva CDB (Clinical Database). This platform helps streamline clinical trial data management, minimizes manual errors, boosts trial efficiency, and speeds up data-driven decision-making in pharmaceutical research and development. Veeva CDB includes features such as anomaly detection, predictive site performance forecasting, generative document drafting, and virtual patient simulations, all within a fully integrated eClinical ecosystem that ensures regulatory traceability. The platform is designed to facilitate the aggregation, cleaning, and transformation of clinical trial data from multiple sources.

In July 2024, Datapharm Ltd., a UK-based company specializing in medicines information, acquired Original Digital Limited for an undisclosed sum. This acquisition aims to improve the accessibility and reliability of medicinal information for healthcare professionals by integrating ODL's SRD search technology into Datapharm's electronic medicines compendium (EMC) platform. Original Digital Limited is a provider of pharmaceutical digital platforms based in the UK.

Major players in the pharmaceutical digital platform market are Johnson & Johnson Services Inc., F. Hoffmann-La Roche Ltd., Merck & Co.Inc., Pfizer Inc., Sanofi SA, Novartis AG, AstraZeneca PLC, Eli Lilly and Company, C.H. Boehringer Sohn AG & Co. KG, Astellas Pharma Inc., GoodRx Holdings Inc., Phreesia Inc., Komodo Health Inc., Truveta Inc., BrightInsight Inc., Formation Bio Inc., Click Therapeutics Inc., Infermedica Sp. z o.o., Medisafe Project Ltd., and Healthera Ltd.

North America was the largest region in the pharmaceutical digital platform market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in pharmaceutical digital platform report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the pharmaceutical digital platform market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The pharmaceutical digital platform market includes revenues earned by entities by providing services such as electronic health record integration, regulatory compliance management, remote consultation, pharmacovigilance monitoring, and supply chain coordination. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Pharmaceutical Digital Platform Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on pharmaceutical digital platform market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
  • Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for pharmaceutical digital platform ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The pharmaceutical digital platform market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

  • Markets Covered:1) By Type: Tele Consultation; In-Person Care; Vaccine Scheduling; Medicine Delivery
  • 2) By Disease: Migraine; Diabetes; Obesity; Pneumococcal Pneumonia; Flu; Others Diseases
  • 3) By End Use: Disease Treatment; Disease Prevention
  • Subsegments:
  • 1) By Tele Consultation: General Consultation; Specialist Consultation; Chronic Disease Management; Mental Health Support; Follow Up Consultation
  • 2) By In-Person Care: Primary Care Visits; Specialist Visits; Laboratory Services; Diagnostic Imaging; Preventive Health Checkups
  • 3) By Vaccine Scheduling: Routine Immunization Booking; Travel Vaccination Scheduling; Pediatric Vaccination Scheduling; Adult Vaccination Scheduling; Mass Vaccination Campaign Scheduling
  • 4) By Medicine Delivery: Prescription Medicine Delivery; Over The Counter Medicine Delivery; Same Day Delivery; Scheduled Delivery; Subscription Refill Delivery
  • Companies Mentioned: Johnson & Johnson Services Inc.; F. Hoffmann-La Roche Ltd.; Merck & Co.Inc.; Pfizer Inc.; Sanofi SA; Novartis AG; AstraZeneca PLC; Eli Lilly and Company; C.H. Boehringer Sohn AG & Co. KG; Astellas Pharma Inc.; GoodRx Holdings Inc.; Phreesia Inc.; Komodo Health Inc.; Truveta Inc.; BrightInsight Inc.; Formation Bio Inc.; Click Therapeutics Inc.; Infermedica Sp. z o.o.; Medisafe Project Ltd.; Healthera Ltd.
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time Series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery Format: PDF, Word and Excel Data Dashboard.
Product Code: r38602

Table of Contents

1. Executive Summary

2. Pharmaceutical Digital Platform Market Characteristics

3. Pharmaceutical Digital Platform Market Trends And Strategies

4. Pharmaceutical Digital Platform Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

  • 4.1. Supply Chain Impact from Tariff War & Trade Protectionism

5. Global Pharmaceutical Digital Platform Growth Analysis And Strategic Analysis Framework

  • 5.1. Global Pharmaceutical Digital Platform PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 5.2. Analysis Of End Use Industries
  • 5.3. Global Pharmaceutical Digital Platform Market Growth Rate Analysis
  • 5.4. Global Pharmaceutical Digital Platform Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
  • 5.5. Global Pharmaceutical Digital Platform Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
  • 5.6. Global Pharmaceutical Digital Platform Total Addressable Market (TAM)

6. Pharmaceutical Digital Platform Market Segmentation

  • 6.1. Global Pharmaceutical Digital Platform Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Tele Consultation
  • In-Person Care
  • Vaccine Scheduling
  • Medicine Delivery
  • 6.2. Global Pharmaceutical Digital Platform Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Migraine
  • Diabetes
  • Obesity
  • Pneumococcal Pneumonia
  • Flu
  • Others Diseases
  • 6.3. Global Pharmaceutical Digital Platform Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Disease Treatment
  • Disease Prevention
  • 6.4. Global Pharmaceutical Digital Platform Market, Sub-Segmentation Of Tele Consultation, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • General Consultation
  • Specialist Consultation
  • Chronic Disease Management
  • Mental Health Support
  • Follow Up Consultation
  • 6.5. Global Pharmaceutical Digital Platform Market, Sub-Segmentation Of In-Person Care, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Primary Care Visits
  • Specialist Visits
  • Laboratory Services
  • Diagnostic Imaging
  • Preventive Health Checkups
  • 6.6. Global Pharmaceutical Digital Platform Market, Sub-Segmentation Of Vaccine Scheduling, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Routine Immunization Booking
  • Travel Vaccination Scheduling
  • Pediatric Vaccination Scheduling
  • Adult Vaccination Scheduling
  • Mass Vaccination Campaign Scheduling
  • 6.7. Global Pharmaceutical Digital Platform Market, Sub-Segmentation Of Medicine Delivery, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Prescription Medicine Delivery
  • Over The Counter Medicine Delivery
  • Same Day Delivery
  • Scheduled Delivery
  • Subscription Refill Delivery

7. Pharmaceutical Digital Platform Market Regional And Country Analysis

  • 7.1. Global Pharmaceutical Digital Platform Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 7.2. Global Pharmaceutical Digital Platform Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Pharmaceutical Digital Platform Market

  • 8.1. Asia-Pacific Pharmaceutical Digital Platform Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Pharmaceutical Digital Platform Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.3. Asia-Pacific Pharmaceutical Digital Platform Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.4. Asia-Pacific Pharmaceutical Digital Platform Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Pharmaceutical Digital Platform Market

  • 9.1. China Pharmaceutical Digital Platform Market Overview
  • 9.2. China Pharmaceutical Digital Platform Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.3. China Pharmaceutical Digital Platform Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.4. China Pharmaceutical Digital Platform Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Pharmaceutical Digital Platform Market

  • 10.1. India Pharmaceutical Digital Platform Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.2. India Pharmaceutical Digital Platform Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.3. India Pharmaceutical Digital Platform Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Pharmaceutical Digital Platform Market

  • 11.1. Japan Pharmaceutical Digital Platform Market Overview
  • 11.2. Japan Pharmaceutical Digital Platform Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.3. Japan Pharmaceutical Digital Platform Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.4. Japan Pharmaceutical Digital Platform Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Pharmaceutical Digital Platform Market

  • 12.1. Australia Pharmaceutical Digital Platform Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.2. Australia Pharmaceutical Digital Platform Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.3. Australia Pharmaceutical Digital Platform Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Pharmaceutical Digital Platform Market

  • 13.1. Indonesia Pharmaceutical Digital Platform Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.2. Indonesia Pharmaceutical Digital Platform Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.3. Indonesia Pharmaceutical Digital Platform Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Pharmaceutical Digital Platform Market

  • 14.1. South Korea Pharmaceutical Digital Platform Market Overview
  • 14.2. South Korea Pharmaceutical Digital Platform Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.3. South Korea Pharmaceutical Digital Platform Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.4. South Korea Pharmaceutical Digital Platform Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Pharmaceutical Digital Platform Market

  • 15.1. Western Europe Pharmaceutical Digital Platform Market Overview
  • 15.2. Western Europe Pharmaceutical Digital Platform Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.3. Western Europe Pharmaceutical Digital Platform Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.4. Western Europe Pharmaceutical Digital Platform Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Pharmaceutical Digital Platform Market

  • 16.1. UK Pharmaceutical Digital Platform Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.2. UK Pharmaceutical Digital Platform Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.3. UK Pharmaceutical Digital Platform Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Pharmaceutical Digital Platform Market

  • 17.1. Germany Pharmaceutical Digital Platform Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.2. Germany Pharmaceutical Digital Platform Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.3. Germany Pharmaceutical Digital Platform Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Pharmaceutical Digital Platform Market

  • 18.1. France Pharmaceutical Digital Platform Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.2. France Pharmaceutical Digital Platform Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.3. France Pharmaceutical Digital Platform Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Pharmaceutical Digital Platform Market

  • 19.1. Italy Pharmaceutical Digital Platform Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.2. Italy Pharmaceutical Digital Platform Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.3. Italy Pharmaceutical Digital Platform Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Pharmaceutical Digital Platform Market

  • 20.1. Spain Pharmaceutical Digital Platform Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.2. Spain Pharmaceutical Digital Platform Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.3. Spain Pharmaceutical Digital Platform Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Pharmaceutical Digital Platform Market

  • 21.1. Eastern Europe Pharmaceutical Digital Platform Market Overview
  • 21.2. Eastern Europe Pharmaceutical Digital Platform Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.3. Eastern Europe Pharmaceutical Digital Platform Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.4. Eastern Europe Pharmaceutical Digital Platform Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Pharmaceutical Digital Platform Market

  • 22.1. Russia Pharmaceutical Digital Platform Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.2. Russia Pharmaceutical Digital Platform Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.3. Russia Pharmaceutical Digital Platform Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Pharmaceutical Digital Platform Market

  • 23.1. North America Pharmaceutical Digital Platform Market Overview
  • 23.2. North America Pharmaceutical Digital Platform Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.3. North America Pharmaceutical Digital Platform Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.4. North America Pharmaceutical Digital Platform Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Pharmaceutical Digital Platform Market

  • 24.1. USA Pharmaceutical Digital Platform Market Overview
  • 24.2. USA Pharmaceutical Digital Platform Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.3. USA Pharmaceutical Digital Platform Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.4. USA Pharmaceutical Digital Platform Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Pharmaceutical Digital Platform Market

  • 25.1. Canada Pharmaceutical Digital Platform Market Overview
  • 25.2. Canada Pharmaceutical Digital Platform Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.3. Canada Pharmaceutical Digital Platform Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.4. Canada Pharmaceutical Digital Platform Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Pharmaceutical Digital Platform Market

  • 26.1. South America Pharmaceutical Digital Platform Market Overview
  • 26.2. South America Pharmaceutical Digital Platform Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.3. South America Pharmaceutical Digital Platform Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.4. South America Pharmaceutical Digital Platform Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Pharmaceutical Digital Platform Market

  • 27.1. Brazil Pharmaceutical Digital Platform Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.2. Brazil Pharmaceutical Digital Platform Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.3. Brazil Pharmaceutical Digital Platform Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Pharmaceutical Digital Platform Market

  • 28.1. Middle East Pharmaceutical Digital Platform Market Overview
  • 28.2. Middle East Pharmaceutical Digital Platform Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.3. Middle East Pharmaceutical Digital Platform Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.4. Middle East Pharmaceutical Digital Platform Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Pharmaceutical Digital Platform Market

  • 29.1. Africa Pharmaceutical Digital Platform Market Overview
  • 29.2. Africa Pharmaceutical Digital Platform Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.3. Africa Pharmaceutical Digital Platform Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.4. Africa Pharmaceutical Digital Platform Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Pharmaceutical Digital Platform Market Competitive Landscape And Company Profiles

  • 30.1. Pharmaceutical Digital Platform Market Competitive Landscape
  • 30.2. Pharmaceutical Digital Platform Market Company Profiles
    • 30.2.1. Johnson & Johnson Services Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.2. F. Hoffmann-La Roche Ltd. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.3. Merck & Co.Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.4. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.5. Sanofi SA Overview, Products and Services, Strategy and Financial Analysis

31. Pharmaceutical Digital Platform Market Other Major And Innovative Companies

  • 31.1. Novartis AG
  • 31.2. AstraZeneca PLC
  • 31.3. Eli Lilly and Company
  • 31.4. C.H. Boehringer Sohn AG & Co. KG
  • 31.5. Astellas Pharma Inc.
  • 31.6. GoodRx Holdings Inc.
  • 31.7. Phreesia Inc.
  • 31.8. Komodo Health Inc.
  • 31.9. Truveta Inc.
  • 31.10. BrightInsight Inc.
  • 31.11. Formation Bio Inc.
  • 31.12. Click Therapeutics Inc.
  • 31.13. Infermedica Sp. z o.o.
  • 31.14. Medisafe Project Ltd.
  • 31.15. Healthera Ltd.

32. Global Pharmaceutical Digital Platform Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Pharmaceutical Digital Platform Market

34. Recent Developments In The Pharmaceutical Digital Platform Market

35. Pharmaceutical Digital Platform Market High Potential Countries, Segments and Strategies

  • 35.1 Pharmaceutical Digital Platform Market In 2029 - Countries Offering Most New Opportunities
  • 35.2 Pharmaceutical Digital Platform Market In 2029 - Segments Offering Most New Opportunities
  • 35.3 Pharmaceutical Digital Platform Market In 2029 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Hi, how can we help?
Contact us!